When did Perspective Therapeutics report Q4 2024 earnings?

Perspective Therapeutics (CATX) reported Q4 2024 earnings on March 26, 2025 after market close.

What were Perspective Therapeutics's Q4 2024 revenue and EPS?

Perspective Therapeutics reported revenue of $234.0K and eps of $-0.25 for Q4 2024.

Did Perspective Therapeutics beat estimates in Q4 2024?

Revenue missed the consensus estimate of $277.3K by $43.3K. EPS beat the consensus estimate of $-0.26 by $0.01.

Where can I find Perspective Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-045242) directly on SEC EDGAR. The filing index links above go to sec.gov.

Perspective Therapeutics CATX Q4 2024 Annual earnings

Reported March 26, 2025 · After market close

Revenue$234.0KMiss by $43.3K

EPS-$0.25Beat by $0.01

Revenue estimate$277.3K

EPS estimate-$0.26

Next report

Aug 12, 2026 (In 1 week)

Revenue estimate$90.5K

EPS estimate-$0.27

Financials

Q4 2024

Income statement

See full

Operating income-$45.0M-285%

Net income-$40.2M-62.8%

EPS (diluted)-$0.61+33.0%

Balance sheet

See full

Cash & equivalents$61.6M+567%

Total debt$4.0M+60.3%

Total equity$290.7M+287%

Total assets$341.1M+248%

Cash flow

See full

Operating cash flow-$26.6M-195%

CapEx$14.6M+16,320%

Free cash flow-$41.2M-353%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$215.6M+91.2%

Enterprise value$158.03M+49.0%

Returns & leverage

See full

Return on equity-43.3%-12.3pp

Debt / equity0×0.0×

Current ratio12.7×+11.6×

Versus estimates

Revenue

Q1 2026$76.0KMiss by $81.4K Q4 2025$43.0KMiss by $189.5K Q2 2025$234.0KBeat by $59.4K Q1 2025$342.0KBeat by $156.1K

Q4 2024$234.0KMiss by $43.3K

Q3 2024$369.0KBeat by $76.2K

Diluted EPS

Q1 2026-$0.25Beat by $0.04 Q4 2025-$0.51Miss by $0.14 Q2 2025-$0.30In line Q1 2025-$0.25Beat by $0.03

Q4 2024-$0.25Beat by $0.01

Q3 2024-$0.21In line

Ask the moment Perspective Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Perspective Therapeutics report Q4 2024 earnings?: Perspective Therapeutics (CATX) reported Q4 2024 earnings on March 26, 2025 after market close.
What were Perspective Therapeutics's Q4 2024 revenue and EPS?: Perspective Therapeutics reported revenue of $234.0K and eps of $-0.25 for Q4 2024.
Did Perspective Therapeutics beat estimates in Q4 2024?: Revenue missed the consensus estimate of $277.3K by $43.3K. EPS beat the consensus estimate of $-0.26 by $0.01.
Where can I find Perspective Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-045242) directly on SEC EDGAR. The filing index links above go to sec.gov.